Wave Life Sciences is a clinical-stage biotechnology company developing RNA medicines (oligonucleotides) through its PRISM platform, which combines RNAi (SpiNA) and RNA editing (AIMers) modalities. Its lead programs include WVE-007, a GalNAc-conjugated siRNA targeting INHBE for obesity; WVE-006, an RNA editing oligonucleotide for alpha-1 antitrypsin deficiency; and WVE-008, an RNA editing oligonucleotide for PNPLA3 I148M liver disease. The company also has clinical programs for Duchenne muscular dystrophy (WVE-N531) and Huntington's disease (WVE-003), using clinically proven GalNAc conjugate delivery rather than lipid nanoparticles or viral vectors.
expected 2027-01-26
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-073472 | EDGAR | 97K words |
| 2025-03-04 | 2024-12-31 | 0000950170-25-031322 | EDGAR | 105K words |
| 2024-03-06 | 2023-12-31 | 0000950170-24-026876 | EDGAR | 104K words |
| 2023-03-23 | 2022-12-31 | 0000950170-23-009319 | EDGAR | 101K words |
| 2022-03-03 | 2021-12-31 | 0001564590-22-008414 | EDGAR | 96K words |
| 2021-03-04 | 2020-12-31 | 0001564590-21-010718 | EDGAR | 101K words |
| 2020-03-02 | 2019-12-31 | 0001564590-20-007972 | EDGAR | 93K words |
| 2019-03-01 | 2018-12-31 | 0001564590-19-005671 | EDGAR | 94K words |
| 2018-03-12 | 2017-12-31 | 0001564590-18-005308 | EDGAR | 88K words |
| 2017-03-16 | 2016-12-31 | 0001564590-17-004649 | EDGAR | 77K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-10-27 | 2026-09-30 | 0001193125-26-432714 | EDGAR | 24K words |
| 2026-07-30 | 2026-06-30 | 0001193125-26-324949 | EDGAR | 23K words |
| 2025-11-10 | 2025-09-30 | 0001193125-25-273288 | EDGAR | 23K words |
| 2025-07-30 | 2025-06-30 | 0000950170-25-099884 | EDGAR | 21K words |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066404 | EDGAR | 19K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124595 | EDGAR | 26K words |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093341 | EDGAR | 23K words |
| 2024-05-10 | 2024-03-31 | 0000950170-24-057457 | EDGAR | 21K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061544 | EDGAR | 24K words |
| 2023-08-03 | 2023-06-30 | 0000950170-23-037601 | EDGAR | 22K words |
| 2023-05-03 | 2023-03-31 | 0000950170-23-016888 | EDGAR | 20K words |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024171 | EDGAR | 23K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-10-27 | 0001193125-26-432690 | EDGAR | 4K words |
| 2026-07-30 | 0001193125-26-324917 | EDGAR | 4K words |
| 2026-03-26 | 0001193125-26-125092 | EDGAR | 2K words |
| 2026-02-26 | 0001193125-26-073437 | EDGAR | 4K words |
| 2026-02-02 | 0001193125-26-032698 | EDGAR | 1K words |
| 2026-01-12 | 0001193125-26-009784 | EDGAR | 7K words |
| 2025-12-11 | 0001193125-25-314746 | EDGAR | 1K words |
| 2025-12-08 | 0001193125-25-310595 | EDGAR | 2K words |
| 2025-11-17 | 0001193125-25-283929 | EDGAR | 6K words |
| 2025-11-10 | 0001193125-25-273278 | EDGAR | 5K words |
246 total filings indexed. 214 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001631574 |
| Ticker | WVE |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | U0 |
| Website | https://www.wavelifesciences.com |
| Listed | 2015-11-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/WVE (~200 tokens, structured JSON with cryptographic provenance)